Ariana Brice-Tutt’s final defense was presented March 10 and titled “Therapeutic and Mechanistic Evaluation of Novel Multifunctional Opioid Ligands: Implications for the Treatment of Opioid Use Disorder and Pain.” Brice-Tutt’s committee consisted of Jane Aldrich, Ph.D., Siobhan Malany, Ph.D., Brandon Warren, Ph.D. and external committee member Yenisel Cruz-Almeida, Ph.D.